Published: 20 September, 2019 | Volume 3 - Issue 1 | Pages: 020-026
Figure 3:
Kaplan-Meier curve showing the probability of developing rebleeding in patients from simvastatin + carvedilol (green) and carvedilol alone (blue) groups (n = 134).
Read Full Article HTML DOI: 10.29328/journal.acgh.1001010 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."